Back to top
more

iShares Biotechnology ETF: (IBB)

(Real Time Quote from BATS) As of May 15, 2024 01:38 PM ET

$137.53 USD

137.53
529,577

+2.06 (1.52%)

Volume: 529,577

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

2 - Buy of 5   2      

ETF Quote Details

Previous Close 135.47
Open 136.54
Bid 137.68
Ask 137.70
Day Low-High 136.38-137.78
52wk Low-High 111.83-141.16
Volume 529,577
NAV (month end) 126.88
Premium (+)/Discount (-) (month end)+8.59

Zacks Premium Research for IBB

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

 Buy 2
ETF Risk

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

High
ETF Research Report

ETF Expense Ratio

Expense Ratio 0.45%
Dividend (Yield) $0.41 (0.30%)
Issuer BLACKROCK

Benchmark for IBB

ICE BIOTECHNOLOGY INDEX

The ICE Biotechnology Index contains securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceuticals.

Fund Summary for IBB

ISHARES BIOTECHNOLOGY ETF

The iShares Biotechnology ETF seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of companies primarily engaged in the biotechnology industry, as represented by the ICE Biotechnology Index.